In “Pathways in cancer”, the accumulation of 4-hydroxynonenal (4HNE) reflects intracellular oxidative stress, which may disrupt PKC signaling by altering the DAG/PA levels [51] (Figure 11B). This evidence concerns the gene PRRT2 and cancer.